What is REGENXBIO Inc.'s Market Cap?

REGENXBIO Inc.'s Market Cap is $441.0M, based on as-reported figures from SEC (XBRL) filings.

What is REGENXBIO Inc.'s Enterprise Value?

REGENXBIO Inc.'s Enterprise Value is $335.5M, based on as-reported figures from SEC (XBRL) filings.

What is REGENXBIO Inc.'s Price / Sales?

REGENXBIO Inc.'s Price / Sales is 2.5×, based on as-reported figures from SEC (XBRL) filings.

What is REGENXBIO Inc.'s EV / Revenue?

REGENXBIO Inc.'s EV / Revenue is 1.9×, based on as-reported figures from SEC (XBRL) filings.

What is REGENXBIO Inc.'s EV / EBITDA?

REGENXBIO Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is REGENXBIO Inc.'s Revenue (TTM)?

REGENXBIO Inc.'s Revenue (TTM) is $174.5M, based on as-reported figures from SEC (XBRL) filings.

What is REGENXBIO Inc.'s Net Income (TTM)?

REGENXBIO Inc.'s Net Income (TTM) is -$196.4M, based on as-reported figures from SEC (XBRL) filings.

What is REGENXBIO Inc.'s EBITDA?

REGENXBIO Inc.'s EBITDA is -$148.8M, based on as-reported figures from SEC (XBRL) filings.

What is REGENXBIO Inc.'s Diluted EPS (TTM)?

REGENXBIO Inc.'s Diluted EPS (TTM) is -2.98, based on as-reported figures from SEC (XBRL) filings.

What is REGENXBIO Inc.'s EBITDA Margin?

REGENXBIO Inc.'s EBITDA Margin is -85.3%, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

REGENXBIO Inc.

XNAS · usd

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG007Z9V5C7

6.68▼ 0.49 (-6.83%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales
EV / Revenue
EV / EBITDA

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt

Trading Information

Previous Close: 7.17
Day's Range: 6.63 – 7.08
52-Week Range: 5.46 – 16.19
Volume: 1.4M
Avg Volume: 1.4M

Share Statistics

Shares Outstanding
Employees: 371
Exchange: XNAS
Listed: 2015-09-17

Share count as of July 31, 2026

REGENXBIO Inc. (RGNX) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about REGENXBIO Inc. (RGNX)

What is REGENXBIO Inc.'s Market Cap?: REGENXBIO Inc.'s Market Cap is $441.0M, based on as-reported figures from SEC (XBRL) filings.
What is REGENXBIO Inc.'s Enterprise Value?: REGENXBIO Inc.'s Enterprise Value is $335.5M, based on as-reported figures from SEC (XBRL) filings.
What is REGENXBIO Inc.'s Price / Sales?: REGENXBIO Inc.'s Price / Sales is 2.5×, based on as-reported figures from SEC (XBRL) filings.
What is REGENXBIO Inc.'s EV / Revenue?: REGENXBIO Inc.'s EV / Revenue is 1.9×, based on as-reported figures from SEC (XBRL) filings.
What is REGENXBIO Inc.'s EV / EBITDA?: REGENXBIO Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is REGENXBIO Inc.'s Revenue (TTM)?: REGENXBIO Inc.'s Revenue (TTM) is $174.5M, based on as-reported figures from SEC (XBRL) filings.
What is REGENXBIO Inc.'s Net Income (TTM)?: REGENXBIO Inc.'s Net Income (TTM) is -$196.4M, based on as-reported figures from SEC (XBRL) filings.
What is REGENXBIO Inc.'s EBITDA?: REGENXBIO Inc.'s EBITDA is -$148.8M, based on as-reported figures from SEC (XBRL) filings.
What is REGENXBIO Inc.'s Diluted EPS (TTM)?: REGENXBIO Inc.'s Diluted EPS (TTM) is -2.98, based on as-reported figures from SEC (XBRL) filings.
What is REGENXBIO Inc.'s EBITDA Margin?: REGENXBIO Inc.'s EBITDA Margin is -85.3%, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · RGNXAs-filed SEC (XBRL) data